Skip to main content
NIH Clinical Center
Home | Contact Us | Site Map | Search
About the Clinical Center For Researchers and Physicians Participate in Clinical Studies

Back to: About the Clinical Center > Departments and Services > Rehabilitation Medicine
Speech and Language Pathology
About Speech and Language Pathology
Clinical Services
Clinical Research
Education and Training
Staff


Staff

Carol Frattali, PhD
Dr. Carol M. Frattali, Research Coordinator, Speech and Language Pathology at the NIH Clinical Center, received her doctorate in speech-language pathology at the University of Pittsburgh, her M.A. in Speech-Language Pathology at the San Francisco State University and her B.S. in Speech-Language Pathology and Audiology at Ithaca College. Her clinical and research interests are in the areas of the neuro-cognitive bases of language and its disorders, with focus in discourse processing, social discourse production, and neuro-linguistic approaches to assessment and treatment in aphasia. Dr. Frattali is the author of numerous peer-reviewed articles and book chapters, and the editor of three textbooks in the field. She is board-certified by the Academy of Neurologic Communication Disorders and Sciences and is an elected Fellow of the American Speech-Language-Hearing Association. She is an Adjunct Professor in the Department of Hearing and Speech Sciences, University of Maryland at College Park, and a Research Professor at The George Washington University, Department of Speech and Hearing Sciences. Dr. Frattali’s areas of independent clinical research include investigations in on-line discourse processing and production in normal and neurologically-disordered clinical populations, with focus on the effects of prefrontal cortex damage and left-hemisphere cortical stroke. Piloting of treatment studies is underway to test innovative and short-term intensive methods involving lexical access and social discourse, and other neuro-linguistic approaches to language treatment in a range of neurologically disordered populations. Her collaborative research studies are focused on evaluating the effects of frontal lobe dementia, primary progressive aphasia and penetrating head injury; the neuroplastic effects of treatment in aphasia; and evaluation in patients with brain tumor and intractable epilepsy.


Beth Solomon, MS, CCC-SLP

Beth Solomon, Clinical and Educational Coordinator, Speech and Language Pathology at the NIH Clinical Center, received her Masters of Science in Speech Language Pathology form Columbia University. She received her Bachelors of Arts in Elementary Education and Bachelors of Science in Communication Disorders from the University of Massachusetts. Her clinical practice and research interests involve speech rehabilitation of head and neck cancer patients, pediatric and adult dysphasia, voice disorders, and craniofacial anomalies. She is recognized as a leader in the area of voice restoration following laryngectomy, and as an Infant and Toddler Specialist by the Governor’s Office for Children, Youth and Families in the State of Maryland. She is the appointed Speech-Language Pathology Liaison to the U.S. Public Health Service and U.S. Surgeon General’s Office. Her collaborative research efforts include the study of speech and swallowing outcomes with various head and neck cancer treatments, and the natural history study of speech, swallowing and voice production in various pediatric genetic and metabolic conditions, as well as outcome measures with various treatments in progressive neurologic diseases. Ms. Solomon has mentored numerous graduate students during clinical internships and is a frequent guest lecturer in many of the local university graduate programs in speech-language pathology. She has presented at numerous state, regional and national meetings and has published extensively in the areas of swallowing, oral motor function, and head/neck cancer and rare diseases and syndromes.



National Institutes
of Health
  Department of Health
and Human Services
 
NIH Clinical Center National Institutes of Health